There is significant genetic heterogeneity in GA-II with some genotype-phenotype correlations, specific mutations in ETFDH have been associated with riboflavin-responsive symptoms as well as a myopathic form related to secondary CoQ10 deficiency (35). Here, ETFDH is linked to coenzyme Q10 deficiency.